End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
9.47 SAR | +0.96% | +2.71% | +52.99% |
Summary
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.
Weaknesses
- With an expected P/E ratio at 33.72 and 28.28 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- The company is highly valued given the cash flows generated by its activity.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- Most analysts agree on a negative opinion with regard to the stock. Indeed, the average consensus issues recommendations to underperform or sell.
- The three month average target prices set by analysts do not offer high potential in comparison with the current prices.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
- The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
Ratings chart - Surperformance
Sector: Food Retail & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+52.99% | 2.89B | - | ||
-8.34% | 38.15B | A- | ||
+12.76% | 35.89B | C | ||
+9.89% | 33.86B | A | ||
+8.94% | 20.12B | B | ||
+2.36% | 14.05B | B | ||
-16.02% | 13B | B- | ||
+16.32% | 11.83B | B- | ||
-.--% | 11.82B | - | - | |
-4.68% | 11.67B | B+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 4161 Stock
- Ratings BinDawood Holding Company